Clinical Trial Detail

NCT ID NCT01156584
Title A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tocagen Inc.

malignant glioma


Toca 511 + Toca FC

Age Groups: adult

No variant requirements are available.